P. Ricordeau

The Best Use of the Charlson Comorbidity Index With Electronic Health Care Database to Predict Mortality

Aurélie Bannay, C. Chaignot, Pierre‐Olivier Blotière et al. · Medical Care · 2015 · 482 citations

Health Professions, Health Sciences, Clinical Classification Systems +16

Pioglitazone and risk of bladder cancer among diabetic patients in France: a population-based cohort study

Anke Neumann, Alain Weill, P. Ricordeau et al. · Diabetologia · 2012 · 279 citations · Full text

Medicine, Pharmacotherapy, Urology +12

Underrepresentation of Elderly People in Randomised Controlled Trials. The Example of Trials of 4 Widely Prescribed Drugs

Cécile Konrat, Isabelle Boutron, Ludovic Trinquart et al. · PLoS ONE · 2012 · 167 citations · Full text

Pharmacy, Pharmacology, Pharmacotherapy +9

Comparison of the Short-Term Risk of Bleeding and Arterial Thromboembolic Events in Nonvalvular Atrial Fibrillation Patients Newly Treated With Dabigatran or Rivaroxaban Versus Vitamin K Antagonists

Géric Maura, Pierre‐Olivier Blotière, Kim Bouillon et al. · Circulation · 2015 · 167 citations · Full text

Medicine, Cardiology, Pharmacotherapy +14

Evidence-based pharmacotherapy after myocardial infarction in France: Adherence-associated factors and relationship with 30-month mortality and rehospitalization

Philippe Tuppin, Anke Neumann, Nicolas Danchin et al. · Archives of cardiovascular diseases · 2010 · 130 citations

Pharmacy, Cardiology, Pharmacotherapy +11